Bahrain approves Pfizer/BioNTech COVID-19 vaccine use


By ELydf
  • World
  • Saturday, 05 Dec 2020

MANAMA, Dec. 4 (Xinhua) -- Bahrain's health regulator on Friday announced the authorization of emergency use of the Pfizer/BioNTech COVID-19 vaccine.

"Bahrain has approved the emergency use of Pfizer/BioNTech COVID-19 vaccine that will be used for high risk groups," said the National Health Regulatory Authority (NHRA).

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In World

WMO urges stronger early warning systems after January extreme weather
U.S. dollar ticks up
Belarus sets record with 10 bln USD food exports in 2025
Polish officials blame Russian domestic spy agency for Dec 29 cyberattacks
Feature: Egypt's Fayoum wetlands find new life as sanctuary for migratory birds
Trump's Justice Department releases massive cache of Jeffrey Epstein files
Gold, silver prices drop sharply
Urgent: Cuba declares international emergency in response to U.S. executive order
Flash: Cuba declares international emergency in response to Trump executive order -- FM
US imposes sanctions on Iran's interior minister, businessman

Others Also Read